Stifel has recently initiated Janux Therapeutics Inc (JANX) stock to Buy rating, as announced on September 6, 2024, according to Finviz. Earlier, on May 30, 2024, Scotiabank had initiated the stock to ...

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham ...

Cantor Fitzgerald upgraded shares of Tourmaline Bio (NASDAQ:TRML – Free Report) to a strong-buy rating in a report published ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...

Without a loan from the German government and the matching funds from the State of Bavaria, Lilium N.V. (NASDAQ:LILM) will ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Former President Donald Trump is trading the rally stage for comedy Thursday night as he headlines the annual Al Smith ...

Closely-watched cases could have implications for areas of corporate law that have come up repeatedly in attorneys' ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...